• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: BIOMARKERS IN MS

OCT – diagnosis and prognosis

November 8, 2023  

ECTRIMS-ACTRIMS 2023 HIGHLIGHTS – FRIDAY, OCTOBER 13 EDITION

October 13, 2023  

ECTRIMS-ACTRIMS 2023 HIGHLIGHTS – WEDNESDAY, OCTOBER 11 EDITION

October 11, 2023  

EYE TRACKING AS A BIOMARKER OF MS SEVERITY (NEUROSOUND PODCAST)

October 3, 2023  

K-index a predictor of T2 lesions in CIS, RIS

September 14, 2023  

MicroRNAs – their potential as MS biomarkers

August 29, 2023  

Novel biomarkers in development for MS

August 14, 2023  

sNfL a useful alternative to gadolinium

July 31, 2023  

EAN HIGHLIGHTS 2023 – WEDNESDAY, JULY 5 EDITION

July 5, 2023  

EAN HIGHLIGHTS 2023 – MONDAY, JULY 3 EDITION

July 3, 2023  
Previous
2
3
4
5
6
Next

Browse by Topic

  • MS (442)
  • EAN 2026 (2)
  • CLINICAL CASES (21)
  • AAN 2026 (3)
  • ACTRIMS Forum 2026 (4)
  • EPILEPSY (38)
  • AES 2025 (1)
  • BIOMARKERS IN MS (61)
  • ECTRIMS 2025 (7)
  • Library (18)
  • EAN 2025 (2)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
  • Ultomiris (ravulizumab) now publicly reimbursed in gMG posted on April 7, 2026
  • Ofatumumab – new data on efficacy and safety posted on April 14, 2025
Copyright 2026 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions